Research underway at Innopharm Labs' pilot facility in Dublin, Ireland, combines the concepts of Industrial Internet of Things (IoT), Industry 4.0, machine-to-machine connectivity and the adoption of artificial intelligence. This approach uses process analytical technology tools to track and control process, laying the groundwork for real-time release and self-guided processing. Ian Jones, CEO Innopharma Labs, will discuss the concepts, lessons they've learned so far, and challenges that remain in making the vision of advanced manufacturing a reality.